A Randomized Pilot of a Tailored Smoking Cessation Quitline Intervention for Individuals Who Smoke and Vape.
Journal
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
ISSN: 1469-994X
Titre abrégé: Nicotine Tob Res
Pays: England
ID NLM: 9815751
Informations de publication
Date de publication:
26 10 2022
26 10 2022
Historique:
received:
13
09
2021
revised:
09
02
2022
accepted:
13
05
2022
pubmed:
17
5
2022
medline:
28
10
2022
entrez:
16
5
2022
Statut:
ppublish
Résumé
Although e-cigarettes are not a federally approved tobacco cessation aid in the United States, many smokers use them to quit or cut down on smoking. Tailored behavioral support could improve rates of complete smoking cessation for those individuals. A novel behavioral treatment to help dual cigarette and e-cigarette users quit smoking was tested in a randomized pilot with a state tobacco quitline. Ninety-six dual users of cigarettes and e-cigarettes were recruited from incoming state quitline callers and randomized to receive enhanced e-cigarette coaching (EEC) or quitline treatment as usual (TAU) to examine EEC feasibility and acceptability. Outcomes at 3 months were treatment satisfaction, engagement, beliefs, and smoking cessation. This pilot was not powered to detect differences in quit rates. Sixty-nine percent responded to the 3-month survey. EEC treatment satisfaction was noninferior to TAU: 93.8% (30/32) of EEC and 73.5% (25/34) of TAU reported being "very satisfied" or "satisfied" with treatment, respectively. EEC participants completed more coaching calls than TAU (M = 3.4 vs. M = 2.7, p = .03), and the majority in both groups elected to receive nicotine replacement therapy (EEC: 100%, TAU: 94%, p = .24). With missing data imputed as smoking, intent-to-treat 7-day point prevalence smoking abstinence rates were 41.3% (19/46) for EEC and 28.0% (14/50) for TAU (p = .20). The EEC quitline intervention for dual cigarette and e-cigarette users demonstrated high levels of treatment satisfaction and engagement. This pilot was not powered to detect significant differences in smoking cessation; however, cessation rates were promising and warrant evaluation in a fully powered trial. If this scalable behavioral treatment to help dual cigarette and e-cigarette users quit smoking proves to be effective in a larger trial, quitlines could implement this harm reduction approach to improve outcomes for callers who already use e-cigarettes and are planning to use them while quitting smoking.
Identifiants
pubmed: 35575085
pii: 6586250
doi: 10.1093/ntr/ntac129
pmc: PMC9596999
doi:
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1811-1820Subventions
Organisme : NCI NIH HHS
ID : P30 CA225520
Pays : United States
Organisme : NIDA NIH HHS
ID : R21 DA042960
Pays : United States
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Circulation. 2014 May 13;129(19):1972-86
pubmed: 24821826
Nicotine Tob Res. 2019 Sep 19;21(10):1299-1309
pubmed: 29718475
J Med Internet Res. 2014 Jan 03;16(1):e2
pubmed: 24389354
Tob Control. 2018 May;27(3):341-346
pubmed: 28624764
Tob Control. 2021 Sep;30(5):578-582
pubmed: 33051278
Cochrane Database Syst Rev. 2019 Apr 18;4:CD013308
pubmed: 30997928
Tob Control. 2021 Nov;30(6):693-695
pubmed: 32958602
N Engl J Med. 2019 Feb 14;380(7):629-637
pubmed: 30699054
N Engl J Med. 2014 Jan 23;370(4):297-9
pubmed: 24450888
Br J Addict. 1989 Jul;84(7):791-9
pubmed: 2758152
Lancet Respir Med. 2020 Jan;8(1):54-64
pubmed: 31515173
Am J Prev Med. 2021 Mar;60(3 Suppl 2):S128-S135
pubmed: 33663700
Cochrane Database Syst Rev. 2020 Oct 14;10:CD010216
pubmed: 33052602
BMJ Open. 2017 Apr 1;7(4):e013079
pubmed: 28365587
Respir Care. 2008 Sep;53(9):1217-22
pubmed: 18807274
Contemp Clin Trials Commun. 2021 Sep 08;24:100845
pubmed: 34568637
Am Psychol. 2000 Jan;55(1):68-78
pubmed: 11392867
Lancet Public Health. 2021 Jul;6(7):e500-e509
pubmed: 34175001
J Family Med Prim Care. 2020 Jun 30;9(6):2615-2620
pubmed: 32984096
Am J Prev Med. 2021 Mar;60(3 Suppl 2):S142-S153
pubmed: 33663702
Nicotine Tob Res. 2020 Jun 12;22(7):1086-1097
pubmed: 31570931